CKD in individuals with CKD

Slides:



Advertisements
Similar presentations
Cardiovascular disease and vascular calcification in CKD
Advertisements

Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
The National Kidney Foundations Kidney Early Evaluation Program TM The National Kidney Foundations Kidney Early Evaluation Program TM Essex-Passaic Wellness.
Multicenter database of clinical course of CKD patients Internal Medicine Jang Hye Ryoun.
Diabetes, Anemia and Chronic Kidney Disease Josephine Carlos-Raboca,M.D., F.P.S.E.M., Endocrinology, Diabetes and Metabolism Makati Medical Center.
Dietary Approach To C Kidney Disease
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Chronic Kidney Disease-Related Mineral and Bone Disorder: Public Health Problem Kerry Willis PhD National Kidney Foundation.
Lysaght, J Am Soc Nephrol, 2002 Number of patients worldwide treated with chronic dialysis from 1990 to ,000 1,490,000 2,500,000.
Chronic Kidney Disease/Dialysis Belinda Jim, MD January 15, 2009.
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
The PREVEND Study: Screening for micro-albuminuria
Journal Club EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events – EVOLVE NEJM Dec 2012 Yuvaraj Thangaraj, M.D. Nephrology Fellow Division.
CKD 1-5d GFR Stages Complications Referral Access/ESRD  Thomas Schumacher.
SLOW- COOKING THE BEANS “OR, HOW TO STOP WORRYING AND APPLY SOME LOVE TO THE KIDNEYS” AN APPROACH TO CKD SARA KATE LEVIN, MD JANUARY 2014.
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Calcium & phosphor disturbance CKD- MBD Dr. Atapour.
 Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease:
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD)
Presenter Disclosure Information Diane Bild, MD, MPH Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention FINANCIAL DISCLOSURE: None.
Welch Center Uniting Medicine & Public Health Prevalence of Albuminuria, and its Relationship to Decreased GFR and Outcomes Josef Coresh, MD, PhD Director,
Lesley Stevens MD Tufts-New England Medical Center
Chronic kidney disease Alternative Names Kidney failure - chronic Renal failure - chronic Chronic renal insufficiency Chronic kidney failure Chronic kidney.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Estimated GFR Based on Creatinine and Cystatin C
Chronic Kidney Disease-Mineral and Bone Disorder
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
Improving Primary Care Treatment of CKD David Feldstein, MD Assistant Professor Department of Medicine UW SMPH.
SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital,
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
Cardiovascular Risk In Chronic Kidney Disease Dr Ginny Quan.
THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY AND RENAL FUNCTION. WHAT'S THE ROLE OF INFLAMMATION? Marquis Hawkins, Ph.D. Postdoctoral Scholar University.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital.
Clinical Trial Results. org Long-Term Prognosis Associated with Coronary Calcification Matthew J. Budoff, MD, Leslee J. Shaw, PhD, Sandy T. Liu, Steven.
Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic.
Dialysis: outcome and complications. Introduction Outcomes – 20%+ of dialysis patients die each year, 3YS diabetics ~50% Technical complications –PD –Haemo.
CKD Dr;BASHARDOOST. CKD –SOME DEFINITIONS IRREVERSIBLE LOSS OF GFR CKD results when a disease process damages the structural or functional integrity of.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Comparison of Asymmetric DimethylArginine Levels and Coronary Artery Calcifications in Different Stages of Chronic Kidney Disease and Kidney Transplantation.
1 Antonio Bellasi, MD Medical manager Genzyme, Italy Chronic Kidney Disease-Mineral Bone Disorders (CKD-MBD)
Hyperphosphataemia in chronic kidney disease Support for education and learning for children and young people’s renal services: slide set March 2013 NICE.
High Coronary Calcification Scores Predict Mortality in Pre-Dialysis CKD Patients Reference: Haas MH. The risk of death in patients with a high coronary.
Framingham and the Muddy Waters Jeffry N. Gerber, MD Denver’s Diet Doctor.
Are We There Yet ? Abdul H. Sankari, MD FACC FCCP.
The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.
Cardiovascular complications in Chronic Kidney Disease Nihil Chitalia Consultant Nephrologist Epsom and St. Heliers’ University Hospital NHS trust - Hopes.
Pierre Delanaye, MD, PhD Department of Nephrology-Dialysis-Transplantation CHU Sart Tilman, Liège BELGIUM.
Association of Chronic Kidney Disease With the Spectrum of Ankle Brachial Index The CHS (Cardiovascular Health Study) Joachim H. Ix, MD, MAS,*†§ Ronit.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
The FAVORIT Study (Folic Acid for Vascular Outcome Reduction in Transplantation) Source Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering.
Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%
Dyslipidemia after Kidney Transplant
Volume 69, Issue 1, Pages (January 2006)
The MASS-DAC Study.
Quantitative Analysis of Abdominal Aortic Calcification in CKD Patients Without Dialysis Therapy by Use of the Agatston Score Kidney Blood Press Res 2013;38:
Copyright © 2015 by the American Osteopathic Association.
Section 3: CKD, CVD and mortality
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
CKD–Mineral and Bone Disorder: Core Curriculum 2011
SAVE: Risk of total mortality associated with reduced kidney function
Figure 1 Types of coronary artery calcification
CKD–Mineral and Bone Disorder: Core Curriculum 2011
Chapter 3: Management of progression and complications of CKD
Volume 67, Pages S51-S58 (June 2005)
Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor?  Peter A. Mccullough, Sandeep Soman  Kidney.
Volume 69, Issue 1, Pages (January 2006)
Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients Kim et al. Am J Nephrol 2016;44:71-80.
Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:  
Presentation transcript:

CKD in individuals with CKD Sylvia E. Rosas, MD, MSCE University of Pennsylvania Philadelphia VA Medical Center 3/19/2011

Objectives Brief overview of pathophysiology of CKD.

All-cause Mortality and CV Events According to Estimated GFR Go, et al All-cause Mortality and CV Events According to Estimated GFR Go, et al. NEJM 2004

CKD is prevalent in CVD 46% 43% Patients With CKD (%) 33% 23% CAD, N=431 AMI, N=14,527 CHF, N=6800 CAD CrCl ≤60 mL/min AMI GFR <60 mL/min CHF GFR ≤60 mL/min CVA GFR ≤60 mL/min Ix, et al., 2003; Anavekar, et al., 2004; Shlipak, et al., 2004, McClellan et al, 2006.

Cause of death with graft function (DWGF) among renal transplant recipients 1988-1997 Ojo, KI 2000

Mean Coronary Calcium Score Dialysis Patients have higher Coronary Calcification Score compared to CAD patients 2500 CAD-no ESRD 2000 Dialysis 1500 Mean Coronary Calcium Score 1000 Coronary calcification is much more marked in dialysis patients than in either patients with coronary artery disease (not on dialysis) or the general population. 500 28-39 40-49 50-59 60-69 Age (years) Adapted from Braun J et al. Am J Kid Dis. 1996;27:394-401.

The people to test are those at greatest risk Diabetes mellitus Hypertension Cardiovascular disease Family members of patients with ESRD Note on pediatric patients: CKD may start with childhood obesity No recommendations for routine testing

Pathological abnormalities; or Definition of CKD Kidney damage for > 3 mo, as defined by structural or functional abnormalities of the kidney, with or w/o decreased GFR, manifest by either Pathological abnormalities; or Markers of kidney damage, including abnormalities in the composition of the blood or urine, or abnormalities in imaging tests GFR < 60 ml/min/1.73m2 for > 3 mo, with or w/o kidney damage

Vascular Calcification Inductive vs. inhibitory process Inductive process Inhibitory process Pyrophosphate MGP, Osteopontin and osteoprotegerin Fetuin (a) Smad 6 BMP2 Cbfa1 Phos, PTH and Vitamin D

Stages of Chronic Kidney Disease (CKD)1 Description GFR (ml/min/1.73m2) Stage 1(National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002)

Major mechanisms of vascular calcification Major mechanisms of vascular calcification. Six different mechanisms that have been proposed to regulate the initiation or progression of vascular calcification are illustrated, along with key molecular mediators where known. The extent to which each of these mechanisms plays a role in vascular calcification in various disease states, including hyperphosphatemia and ESRD, is currently unknown. cMGP; gamma carboxylated matrix gla protein, pOPN; phosphorylated osteopontin. Giachelli, KI 2009

Ca load in the vessel wall is high in patients on dialysis Calcium accumulation in the vessel wall begins predialysis Figure 1. Quantification of Ca load in the vessel wall. (A) Dialysis vessels had a significantly higher Ca load compared with predialysis or normal vessels (P0.0001, ANOVA). (B) von Kossa staining demonstrated the absence of calcification in controls, whereas dialysis vessel showed speckled calcification (arrows) in the media and along the internal elastic lamina. M indicates media; Ad, adventitia; and Ca, calcium. Medium-sized muscular arteries routinely removed at omentectomy during a peritoneal dialysis catheter insertion or at renal transplantation in 34 patients with CKD were compared with mesenteric arteries removed at planned intra-abdominal surgery in 6 disease free, age-matched controls. Shroff et al . Dialysis Induces Apoptosis and Vascular Calcification. Circulation. 2008;118;1748-1757.

Dialysis leads to VSMC apoptosis Shroff et al . Circulation 2008 Figure 3. Cell number and apoptosis in vessels. (A)VSMC nuclei per unit area of vessel were counted on a hematoxylin-eosin stained sample to determine the number of VSMCs in different vessel types. There was no reduction in the number of VSMCs in predialysis compared with control vessels, but cell numbers were significantly reduced in dialysis vessels. (B) There was no increase in the number of apoptotic cells in predialysis as compared with normal vessels, but dialysis vessels showed significantly more apoptosis. (C) Staining for smooth muscle cell actin (top) was reduced, as was cell number in dialysis vessels compared with controls. Arrows indicate areas of cell loss in the dialysis vessel. TUNEL staining (middle) was present in dialysis vessels but absent in controls. Von Kossa staining (bottom) showed that areas of medial calcification in dialysis vessels localized to regions that were also TUNEL-positive in adjacent sections. No TUNEL positivity or calcification were observed in control vessels. VSMC indicates vascular smooth muscle cells; M, media; Ad, adventitia; -SM actin, smooth muscle cell actin; and TUNEL, terminal deoxynucleotidyl transferase mediated dUTP nick end abeling. Figure 5. Deposition of calcification inhibitors.(A) Dialysis vessels showed maximum fetuin-A positivity as compared with predialysis or normal vessels (P0.03). (B) Dialysis vessels had more Glu compared with Gla MGP: Gla/ Glu0.40.1 compared with predialysis (1.020.1) or normal (1.50.2) vessels (P0.02). (C) Immunohistochemistry for fetuin-A (top) confirmed significantly greater fetuin-A positivity in dialysis as compared with predialysis or normal vessels. Immunohistochemistry for Gla and Glu MGP (middle and bottom) showed increased amounts of Glu compared with Gla-MGP in dialysis, whereas control vessels had predominantly Gla-MGP. Gla indicates carboxylated; Glu, undercarboxylated; MGP, matrix Gla-protein; M, media; and Ad, adventitia.

Dialysis leads to VSMC apoptosis Shroff et al . Circulation 2008 heteropycnotic nuclei Cytoplasmic vacuoles and matrix vesicles Normal vesicular debris TEM showed (a) a normal contractile VSMC showing a normal nucleus with heterochromatic areas localized predominantly around the nuclear envelope. The euchromatin is interspersed with heterochromatin in the deeper regions of the nucleus. Arrowheads indicate dense bodies indicative of a contractile cell. (b) Interspersed with normal VSMCs were contractile cells with evidence of damage showing heteropycnotic nuclei (large arrow), with highly increased electron density of heterochromatin and much less euchromatin. Cytoplasmic vacuoles and matrix vesicles were deposited in the extracellular matrix adjacent to the plasma membrane. Boxed area is enlarged to show vesicles. (c) Many cells had undergone cell death leaving cellular debris, including vesicular debris (boxed area enlarged). (d) In some areas, vesicles stained with high contrast, indicating the presence of mineral (arrow). (e) The origin of vesicles from budding of the plasma membrane is shown (arrow). Bar1 m. M indicates media; Ad, adventitia; TEM, transmission electron microscopy.

Risk Factors for Vascular Calcification in CKD Intima Media Dyslipidemia √ Advanced age HTN Reciprocal Male Smoking Diabetes Inflammation √ (local) √ (systemic) Goodman et al, AJKD 2004

Risk Factors for Vascular Calcification in CKD Intima Media Reduced GFR √ Hypercalcemia Positive Ca balance Hyperphosphatemia PTH abnormalities Vitamin D administration Duration of treatment with dialysis Goodman et al, AJKD 2004

Electron Beam Tomography

EBCT Coronary Calcium Scoring Area = 15 mm2 Peak CT = 450 Score = 15 x 4 = 60 Area = 8 mm2 Peak CT = 290 Score = 8 x 2 = 16 Total Score = S Hn x-factor (Agatston Scoring) 130-199 1 200-299 2 300-399 3 >400 4

Types of Vascular Calcification Atherosclerosis Intimal Calcification Medial Calcification or Mönckeberg’s sclerosis

Association between CRP and WBC quintiles and coronary calcification Roe, Rosas, Atherosclerosis, 2010

Roe, Rosas, Atherosclerosis, 2010 Mortality and cardiovascular event free survival in patients with and without CAC No CAC CAC Roe, Rosas, Atherosclerosis, 2010

Coronary calcification predicts cardiovascular events and mortality Roe, Rosas, Atherosclerosis, 2010

Change in CAC score over time in renal transplant recipients Schankel, Rosas AJT 2007

Schankel, Rosas AJT 2007

Roe, Rosas, Atherosclerosis, 2010 Coronary calcification progression predicts cardiovascular events and mortality n = 87 Roe, Rosas, Atherosclerosis, 2010

Sylvia.rosas@uphs.upenn.edu